HHS Reg Reform Panel To Review FDA Example Of “Best Practices”
Executive Summary
The HHS Advisory Committee on Regulatory Reform will hear a presentation from the Center for Drug Evaluation & Research as an example of "best practices" during its inaugural meeting
You may also be interested in...
HHS Reg Reform Committee To Discuss Adverse Event Reporting June 10
HHS' advisory committee on regulatory reform will discuss adverse event reporting during its June 10-11 meeting in Minneapolis, Minn
HHS Reg Reform Committee To Discuss Adverse Event Reporting June 10
HHS' advisory committee on regulatory reform will discuss adverse event reporting during its June 10-11 meeting in Minneapolis, Minn
CBER Lot Release Requirement Should Be Eliminated – PhRMA
The lot release requirement for biologics should be eliminated, the Pharmaceutical Research & Manufacturers of America maintained in comments submitted to the HHS Advisory Committee on Regulatory Reform